SEC Form 4 · accession 0001179110-17-015851
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jane Huang
Officer — CMO, Hematology
Period of report
Dec 21, 2017
Accepted (ET)
Dec 22, 2017 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF1 | Dec 21, 2017 | M | 1,000 | $29.51 | A | 1,000 | D | |
| American Depositary SharesF1 | Dec 21, 2017 | S | 1,000 | $98.00 | D | 0 | D | |
| Ordinary Shares | holding | — | — | — | 264,900 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F2,F3 | $2.27 | Dec 21, 2017 | M | 13,000 | D | — | Sep 2, 2026 | Ordinary Shares | 1,367,500 | 1,367,500 | D |
Explanation of responses
- F1Each American Depositary Share represents 13 Ordinary Shares.
- F2The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our American Depositary Shares ("ADSs") on the date of grant, as each ADS represents 13 ordinary shares.
- F3These securities vest over a four-year period as follows: 25% on the first anniversary of September 2, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events.